Objective: The use of endophenotypes, such as neurological soft signs (NSS), is advocated as one possible method to elucidate the heterogeneity of schizophrenia. Exploring the associations between NSS and specific illness symptoms has revealed some trends, although results have been conflicting. To date, such studies have been conducted largely on Caucasian populations and our pilot study represents the first attempt to gather such data in a homogenous African population. Method: Fifty-one patients, all of Xhosa ethnicity and participating in a larger schizophrenia genetic study were recruited. NSS were evaluated using a modified Neurological Evaluation Scale. Data were analysed using SPSS with the strength of the overall relationships between NES groups and SANS and SAPS components analyzed by means of canonical correlation analysis. Results: The canonical correlation of SANS domains (excluding asociality) with the NES conceptual groups was 0.53 (SE=0.11, p=0.024) and of the SAPS domains 0.38 (SE=0.13, p=0.943). Conclusion: Our results suggest a correlation between negative symptoms of schizophrenia and the presence of NSS, supporting the recruitment of a larger sample to more comprehensively evaluate a possible role for NSS as an endophenotype in the Xhosa schizophrenia population. Taking into account that NSS evaluations allow for inexpensive, relatively easy-to-do objective evaluations, this method presents us with a valuable research tool that can be used effectively within our under-resourced environment to help inform on the neurobiological substrate of schizophrenia.
Introduction
Schizophrenia is a severe chronic psychiatric disorder that shows considerable clinical heterogeneity which arguably reflects the heterogeneous nature of susceptibility factors for the illness. 1 Currently there is uncertainty as to whether this is a single disorder with different clinical manifestations or in fact a group of syndromes, each with unique or overlapping pathophysiology.
Considerable attempts have been made to elucidate the heterogeneity of the schizophrenia phenotype by exploring the relationships between the various symptom dimensions and possible subtypes. One possible method would be to consider a role for endophenotypes. Several approaches have been advocated for endophenotype analysis in schizophrenia, such as demographic and clinical variables, physical characteristics and neurodevelopmental insults. 2 The neurodevelopmental hypothesis of schizophrenia holds that the etiological origins of the disease can be traced back to disturbed early prenatal development. [3] [4] [5] Currently, numerous diverse lines of evidence support this hypothesis, including the presence of obstetric complications, epidemiological data (i.e. in utero disease and stress exposure), the presence of pre-morbid behavioral and neuromotor deficits, the observed pattern of developmental brain anomalies, the increased rate of dysmorphic features and a higher frequency of neurological soft signs. [6] [7] [8] [9] [10] [11] [12] Neurological "subtle" or "soft" signs (NSS) are
Neurological soft signs as an endophenotype in an African schizophrenia populationa pilot study abnormalities that illustrate generalised and non-specific neurological pathology and a large body of literature exists that consistently supports an excess of NSS in schizophrenia patients. 13 These seem to mainly be localized to the three neurological domains conceptualized (based on neuroanatomy and function) by Buchanan and Heinrichs. 14 These are integrative sensory function (deficits possibly resulting from a dysfunction of the heteromodal cortex), motor coordination (deficits possibly related to basal ganglia abnormalities) and sequencing of complex motor tasks (deficits possibly resulting from a dysfunction of the frontobasal ganglial circuitry). 15, 16 Several authors have attempted to search for an association between NSS and specific symptoms of schizophrenia. 17, 18 Results have often been conflicting although trends for relationships with specifically negative symptoms and disorganization seem to have emerged. [19] [20] [21] [22] [23] [24] [25] To date, NSS schizophrenia symptom correlation studies have been conducted largely on Caucasian populations and as such this pilot study represents the first attempt to gather such data in a homogenous African population.
Method

Subjects
Over a period of 24 months, a group of potential participants, all of Xhosa (African population of the Nguni language group) ethnicity and known to have a diagnosis of schizophrenia, were recruited from in-and outpatient hospital services and community clinics in the Western Cape Province of South Africa for participation in an international genetic study. 26 The larger study methodology is fully documented in previous publications from our group. 27 In conjunction with the abovementioned a number of sub-projects were also initiated concurrently, using convenience samples from the larger study population. All of the subjects who presented for assessment for one such study were approached in consecutive order by a Xhosa-speaking social scientist to discuss possible participation in this study. Of the 51 patients approached, all agreed to participate. Once again subjects were screened as according to the inclusion and exclusion criteria and informed consent was obtained prior to any study procedures being initiated. Assessments A diagnosis of schizophrenia was confirmed using the Diagnostic Interview for Genetic Studies (2.0), (DIGS). 28 The interview was conducted in English and/or Xhosa, and supporting information was obtained from collateral sources. The DIGS is a comprehensive clinical assessment interview specially developed for diagnosing major mood and psychotic spectrum disorders and also includes the Schedules for the Assessment of Positive and Negative Symptoms (SAPS, SANS). 29, 30 The SANS and SAPS each assess symptom complexes to obtain clinical ratings of negative and positive symptoms respectively in patients with schizophrenia and domain scores were derived by summing the items.
One clinician evaluated NSS in the study population using a modified Neurological Evaluation Scale (NES). 14 The modified NES was based on those items previously selected by Emsley et al in a South African population and Keshevan et al whose modifications consisted of discarding those items that were abnormal in less than 10% of their samples. 16, 31 Data analysis Data were analysed using SPSS software (version 13.0). For analysis items were divided according to a conceptual framework for neurological "soft signs", putting items into 4 groups namely sensory integration (sensory), motor coordination (motor), sequencing of complex motor acts (sequencing) and others. 14 (Table I ). The strength of the overall relationships between the four groups and SANS components (affective changes, alogia, avolition/apathy and asociality) and SAPS components (hallucinations, delusions, thought disorder, behavioural changes) were analyzed by means of canonical correlation analysis as this method allowed us to simultaneously predict multiple dependent variables from multiple independent variables. 32 
Ethical Considerations
The study was approved by the Committee for Human Research, Faculty of Health Sciences, University of Stellenbosch (97/005) and all their regulations were strictly adhered to. The canonical correlation of SANS domains (excluding asociality) with the NES conceptual groups is 0.53 (SE=0.11, p=0.024). The first canonical variable (V1) for NES conceptual groups is a weighted difference of motor, sequencing, others and sensory, while the first canonical variable (W1) for the SANS domains is a weighted average of alogia, avolition and affective changes (see Table III ).
The canonical correlation of the SAPS domains with the NES groups is 0.38 (SE=0.13, p=0.943). The first canonical variable (V1) for NES is as described above, while the first canonical variable (W1) for SAPS domains is a weighted average of the four variables hallucinations, delusions, behavioural changes and thought disorder (see Table IV ). Significant correlations between the NES groups and SANS components, but not the SAPS components could thus be demonstrated.
Discussion
Our results suggest a correlation between negative symptoms of schizophrenia and the presence of neurological soft signs in our study population. A number of studies have found a positive relationship between NSS and clinical correlates in schizophrenia. 17, 33 Whilst reported results have at times been conflicting, the association between NSS and negative symptoms seems particularly robust. 13, [19] [20] [21] [22] [23] [24] [25] However, this association has not been confirmed by all studies. [34] [35] [36] Rather the link seems to be more clear in samples with a severe or chronic illness outcome eg persistence of negative symptoms in spite of adequate antipsychotic treatment. 37, 38 Our sample seems to fit this mould, taken into account the mean duration of illness and presence of ongoing positive and negative symptoms as evidenced by the SANS and SAPS. In their review Tosato and Dazzan commented that the association between an excess of NSSs and a negative syndrome seemed appropriate as it could well be explained by the hypothesis that negative symptoms are the behavioural correlates of an underlying central nervous system disorder possibly involving a dysfunction in the cerebellum and affecting the integrity of the frontal lobe. 33 As previously noted a paucity of data exist regarding associations between clinical correlates and NSS in nonCaucasian populations. In fact, very few studies have investigated a possible effect for ethnicity on NSS. Available data suggest increased NSS in African patients in comparison to Caucasians, in contrast to Asian patients where no significant differences were found. 14, 38, 39 In their comprehensive review of NSS as a possible endophenotype in schizophrenia Liu et al conclude that in spite of the many challenges it is much too early to disregard the usefulness of the role NSS could play. 17 Our pilot study's findings support this and the recruitment of a larger sample to more comprehensively evaluate a possible role for NSS as an endophenotype in the homogenous Xhosa schizophrenia population seems warranted.
Conclusion
Taking into account that NSS evaluations allow for inexpensive, relatively easy-to-do objective evaluations, this method presents us with a valuable research tool that can be used effectively within our under-resourced environment to help inform on the neurobiological substrate of the schizophrenia. The suggested excess of NSS in homogenous African populations provides further support for its use as a marker for study in this group. 
